Pancreatic Cancer Research

ResearcherTranslational Genomics Research InstituteNo recent work listed

Serina Ng

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers

Papers 7

  1. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Co-author DOI 10.1038/s41467-023-42178-6↗
  2. Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer. Co-author DOI 10.1038/s41598-023-44211-6↗
  3. Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2022.11.016↗
  4. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Co-author DOI 10.1016/j.medj.2021.12.008↗
  5. A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer. First author DOI 10.1002/mc.23339↗
  6. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Co-author DOI 10.1038/s41389-020-00285-9↗
  7. Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer. First author DOI 10.1371/journal.pone.0183871↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haiyong Han · 7 shared papers, 2017–2023 · strength 0.91
  2. Daniel D. Von Hoff · 6 shared papers, 2017–2023 · strength 0.78
  3. Ronald M. Evans · 3 shared papers, 2020–2023 · strength 0.35
  4. Gaoyang Liang · 2 shared papers, 2022–2023 · strength 0.25
  5. Corina E. Antal · 2 shared papers, 2020–2023 · strength 0.23
  6. Gabriela R. Rossi · 1 shared paper, 2023 · strength 0.18
  7. Sudhakar Ammanamanchi · 1 shared paper, 2021 · strength 0.13
  8. Akihisa Kato · 1 shared paper, 2021 · strength 0.13
  9. Sushovan Guha · 1 shared paper, 2021 · strength 0.13
  10. Yu Shi · 1 shared paper, 2023 · strength 0.13
  11. Tony R. Hunter · 1 shared paper, 2023 · strength 0.13
  12. Dannielle D. Engle · 1 shared paper, 2023 · strength 0.13
  13. Hervé Tiriac · 1 shared paper, 2023 · strength 0.13
  14. Wenyun Lu · 1 shared paper, 2022 · strength 0.12
  15. Michel Nofal · 1 shared paper, 2022 · strength 0.12
  16. Matthew Joseph McBride · 1 shared paper, 2022 · strength 0.12
  17. Lifeng Yang · 1 shared paper, 2022 · strength 0.12
  18. Joshua D. Rabinowitz · 1 shared paper, 2022 · strength 0.12
  19. Pawan Noel · 1 shared paper, 2020 · strength 0.10
  20. Wei Lin · 1 shared paper, 2020 · strength 0.10
  21. Clifford J. Whatcott · 1 shared paper, 2017 · strength 0.08
  22. Michael T. Barrett · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.